*The Optometric Society released its newest brochure, “Eye Before See” at SECO 2015. The “Eye Before See” Initiative is a public awareness campaign emphasizing the importance of having an eye health examination, and not just refraction alone. The brochure highlights and educates the public that just because someone has 20/20 vision, it does not mean that they have a healthy eye. Copies of the brochure are available for purchase upon request, and can be distributed when speaking in your local communities, public service organizations, schools or have available in your office for your patients. You can view the brochure by clicking here.
The public often believes that refraction alone is an eye exam. This brochure and the Eye Before See Initiative is an easy way to educate the public on the importance of having a comprehensive eye exam to make certain their eyes are healthy for good sight now and into the future.
“Eye Before See: A healthy eye is needed to have and maintain good sight”.
Join your colleagues and friends in Dallas, TX for our 6th year of continuing education. We listened to your feeback and have made this year better than ever:
More topics than ever - 14 COPE-approved hours in all
- Convenient location - close to the airport for easy access with complimentary airport shuttle
- Great Value - group rate of only $99/night at the DFW Airport Marriott South
- Reception - Breakfast - Lunch included
- Early-bird Discount through January 31st!
The Medical Board of California responds to the TOS letter regarding Opternative:
MEDICAL BOARD OF CALIFORNIA
Central Complaint Unit
EDMUND G. BROWN JR., Governor
November 26, 2014
The Optometric Society
P.O. Box 8288
La Jolla, CA 92038
Dear Board of Directors:
The Medical Board of California (Board) is in receipt of your recent correspondence regarding Opternative. In this letter you expressed your concerns about the possibility patients may not be receiving treatment within the accepted standard of care if ophthalmologists use this technology.
The Board welcomes any information you may have which indicates one of our licensees may be providing treatment to a patient which is not
by Gary S. Litman, OD, FAAO
I practice full scope optometry with an emphasis on medical eye care. Since the beginning of 2014 and increasingly getting worse, I have experienced a growing number of denials for branded prescriptions. This has compromised my ability to treat patients with the most effective medications. I have been waiting for organized optometry to address this issue, but so far I have not observed any discussion.
I stay up-to-date on the newest and most effective treatments via medications and technology. On every front, we are seeing a push for optometrists to become more medically oriented. My concern is that insurers and pharmacies are preventing me from prescribing these new, more effective medications.
In recent months, in every category of ophthalmic drugs I E-Prescribe, I receive a significant number of denied branded drugs with a recommendation for generics or OTC drugs. I have observed on occasion, pharmacies substituting generics for branded drugs without my consent. I have observed patients who have the same insurance for the previous two years and have been taking specific branded drugs effectively get denials and a request for prior authorization. Most of these drug denials are